Skip to main content
SpringerLink
Log in

Acute studies on safety index of nonsteroidal anti-inflammatory drugs in rats

  • Published:
InflammoPharmacology Aims and scope Submit manuscript

Abstract

Nonsteroidal anti-inflammatory drugs (NSAIDs) are commonly used to treat pain and inflammation. Their use is frequently limited by gastrointestinal side effects, ranging from dyspeptic symptoms to life threatening bleeding or perforations of gastroduodenal ulcers. The present study mainly aimed to establish a safety index of NSAIDs in experimental animals. Safety index is based on the ratio of ulcerogenic dose (UD50) and anti-inflammatory dose (ED50). The safety index of preferential COX-2 inhibitor (nimesulide, meloxicam) was investigated using carrageenan-induced paw oedema and acute ulcerogenic model in rats, compared with the classical NSAIDs (naproxen, indomethacin). Meloxicam was found to be the most potent NSAID (ED50 1.07 mg/kg, p.o.) followed by nimesulide (2.42 mg/kg, p.o.), indomethacin (2.72 mg/kg, p.o.) and naproxen (6.82 mg/kg, p.o.) after 240 min of carrageenan challenge. In acute ulcerogenic study naproxen, indomethacin and meloxicam were found to be ulcerogenic at lower doses (UD50 14.0, 3.80 and 3.21 mg/kg, p.o.) in comparison to nimesulide (UD50 24.52 mg/kg, p.o.). Meloxicam, naproxen and indomethacin also produced damage to gastric epithelium (disruption of mucus layer and damage to parietal cells) at ED50 dose level when it was viewed under scanning electron microscope, but nimesulide did not distrub gastric mucosal integrity at ED50 dose. Based on the safety index (Ulcerogenic dose50 /Effective anti-inflammatory dose50) the order of safety of these agents was nimesulide > meloxicam > naproxen > indomethacin.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

REFERENCES

  1. Churchill, I., Graham, A. G., Shih, C. K., et al. (1996). Selective inhibition of human cyclooxygenase-2 by meloxicam, Inflammopharmacol. 4, 125–135.

    Google Scholar 

  2. Dearden, J. C. and Nichlosan, R. M. (1984). Correlation between gastric irritancy and anti-inflammatory activity of non-steroidal anti-inflammatory drugs, J. Pharm. Pharmacol. 36, 713–715.

    PubMed  Google Scholar 

  3. Dendrinu-Samara, C., Tsotsou, G., Ekaterinia-Dou, L. V., et al. (1998). Anti-inflammatory drugs interacting with Zn(II), Cd(II) and Pt(II) metal ions, J. Inorg. Biochem. 71, 171–179.

    PubMed  Google Scholar 

  4. Elliott, S. L., Ferris, R. J., Giraud, A. S., et al. (1996). Indomethacin damage to rat gastric mucosa is markedly dependent on luminal pH, Clin. Exp. Pharmacol. Physiol. 23, 432–434.

    PubMed  Google Scholar 

  5. Emery, P. (1996). Clinical implcations of selective cycloxygenase-2 inhibition, Scand. J. Rheumatol. 25, 23–28.

    Google Scholar 

  6. Engelhardt, D., Homma, D., Schiegel, K., et al. (1995). Anti-inflammatory, analgesic, an-tipyretic and related properties of meloxicam, a new non-steroidal anti-inflammatory agent with favourable gastrointestinal tolerance, Inflamm. Res. 44, 423–433.

    Google Scholar 

  7. Flegler, S. L., Heckman, J. W. and Klumparens, K. L. (1993). Scanning and Transmission Electron Microscopy: An introduction. W. H. Freeman, New York, pp. 151–159.

    Google Scholar 

  8. Garcia Rodriguez, L. A. and Jick, H. (1994). Risk of upper gastrointestinal bleeding and perforation associated with individual non-steroidal anti-inflammatory drugs, The Lancet 343, 769–772.

    Google Scholar 

  9. Giercksky, K. E., Huseby, G. and Rugstad, H. E. (1989). Epidemiology of NSAIDs-related gastrointestinal side effects, Scand. J. Gastroenterol. Suppl. 163, 3–8.

    PubMed  Google Scholar 

  10. Hawkey, C. J. (1999). COX-2 inhibitors, The Lancet 353, 307–314.

    Google Scholar 

  11. Hogman, C. A. M., Schanker, L. S., Tocco, D. J., et al. (1957). Absorption of drugs from the stomach, J. Pharmacol. Exp. Ther. 120, 540–545.

    PubMed  Google Scholar 

  12. Ivey, K. J. (1988). Mechanisms of non-steroidal anti-inflammatory drug-induced gastric damage: Actions of therapeutic agents, Am. J. Med. 84 (Suppl. 2A), 41–48.

    PubMed  Google Scholar 

  13. Jain, N. K., Singh, A. and Kulkarni, S. K. (1999). Analgesic, anti-inflammatory and ulcerogenic activity of a zinc-naproxencomplex in mice and rats, Pharm. Pharmacol. Commun. 5, 603–607.

    Google Scholar 

  14. Kulkarni, S. K. and Varghese, N. P. (1998). COX-2, TNF-α and apoptosis: newer strategies in inflammatory disorders, Indian Drugs 35, 245–260.

    Google Scholar 

  15. Kulkarni, S. K., Jain, N. K. and Singh, A. (2000). Cyclooxygenase isoenzymes and newer therapeutic potential for selective COX-2 inhibitors, Methods Find. Exp. Clin. Pharmacol. 22 (5), 291–298.

    PubMed  Google Scholar 

  16. Langman, F. J. S., Weil, J., Wainwright, P., et al. (1994). Risk of bleeding peptic ulcer associated with individual non-steroidal anti-inflammatory drugs, The Lancet 343, 1075–1078.

    Google Scholar 

  17. Langman, M. J., Brooks, P., Hawkey, C. J., et al. (1991). Nonsteroidal and anti-inflammatory drug associated ulcer: epidemiology, causation and treatment, J. Gastroenterol. Hepatol. 6, 442–449.

    PubMed  Google Scholar 

  18. Larkai, E. N., Smith, J. L., Lidsky, M. D., et al. (1987). Gastroduodenal mucosa and dyspeptic symptoms in arthritis patients during chronic nonsteroidal anti-inflammatory drugs use, Am. J. Gastroenterol. 82, 1153–1158.

    PubMed  Google Scholar 

  19. Mandell, B. F. (1999). COX-2 selective NSAIDs: biology, promises and concerns, Cleveland Cli. J. Med. 66, 285–292.

    Google Scholar 

  20. Paakari, H. (1994) Epidemiological and financial aspects of the use of nonsteroidal anti-inflammatory analgesics, Pharmacol. Toxicol. 75 (Suppl. 2), 56–59.

    PubMed  Google Scholar 

  21. Patrrignani, P., Panara, M. R. and Santini, G. (1996). Differential inhibition of cyclooxygenase activity of prostaglandin endoperoxide synthase isozymes in vitro and ex vivo in man, Prost. Leuk. Essent. Fatty Acids 55 (Suppl.), P 115.

    Google Scholar 

  22. Rainsford, K. D. (1999). Profile and mechanisms of gastrointestinal and other side effects of nonsteroidal anti-inflammatory drugs (NSAIDs), Am. J. Med. 107 (6A), 27S–35S; discussion 35S–36S.

    Google Scholar 

  23. Singh, S., Sharda, N. and Mahajan, L. (1999). Spectrophotometric determination of pKa of nimesulide, Int. J. Pharmaceutics 176, 261–264.

    Google Scholar 

  24. Takeuchi, K., Ukawa, H., Konaka, A., et al. (1998). Effects of nitric oxide-releasing aspirin derivative on gastric functional and ulcerogenic responses in rats: comparison with plain aspirin, J. Pharmacol. Exp. Ther. 286, 115–121.

    PubMed  Google Scholar 

  25. Vane, J. R. and Botting, R. M. (1998). Anti-inflammatory drugs and their mechanism of action, Inflamm. Res. 47 (Suppl. 2), S78–S87.

    PubMed  Google Scholar 

  26. Vane, J. R. and Botting, R. M. (1995). New insights into the mode of action of anti-inflammatory drugs, Inflamm. Res. 44, 1–10.

    PubMed  Google Scholar 

  27. Wallace, J. L. (1997). Nonsteroidal anti-inflammatory drugs and gastroenteropathy: the second hundred years, Gastroenterology 112, 1000–1016.

    PubMed  Google Scholar 

  28. Wallace, J. L., Chin, B. C. (1997). New generation NSAIDs: the benefits without the risks, Drugs of Today 33, 371–378.

    Google Scholar 

  29. Warner, T. D., Giuliano, F., Vojnvic, I., et al. (1999). Nonsteroidal drug selectivities for cyclooxygenase-1 rather than cyclooxygenase-2 are associated with human gastrointestinal toxicity: a full in vitro analysis, Proc. Natl. Acad. Sci. USA 96, 7563–7568.

    PubMed  Google Scholar 

  30. Winter, C. A., Risley, G. A. and Nuss, G. W. (1962). Carrageenan induced oedema in hind paw of the rat as an assay for anti-inflammatory drugs, Proc. Soc. Exp. Biol. Med. 3, 544–547.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Pharmacology Division, University Institute of Pharmaceutical Sciences, Panjab, University, Chandigarh-, 160 014, India

    Naveen K. Jain & S. K. Kulkarni

  2. R&D Division, Panacea Biotec Ltd., P.O. Lalru, Chandigrah Road, Punjab-, 140 501, India

    Amarjit Singh

Authors
  1. Naveen K. Jain
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S. K. Kulkarni
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Amarjit Singh
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jain, N.K., Kulkarni, S.K. & Singh, A. Acute studies on safety index of nonsteroidal anti-inflammatory drugs in rats. Inflammopharmacology 9, 229–240 (2001). https://doi.org/10.1163/156856001760209770

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1163/156856001760209770

Search

Navigation